Omeros Corp (NASDAQ:OMER)

Data as of Apr 15
 -0.07 / -0.61%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Omeros Corp. is a clinical stage biopharmaceutical company engages in discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. Its products are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. The company also has a deep and diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. Omeros was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Contact Information

Omeros Corp.
201 Elliott Avenue West
Seattle Washington 98119
P:(206) 676-5000
Investor Relations:



Mutual fund holders9.36%
Individual stakeholders8.39%
Other institutional21.68%

Top Executives

Gregory A. DemopulosChairman, President, CEO & Treasurer
Michael A. JacobsenChief Accounting Officer & Vice President-Finance
George A. GaitanarisChief Scientific Officer & Vice President
J. Steven WhitakerChief Medical Officer & VP-Clinical Development
Kenneth M. FergusonChief Development Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.